ClinicalTrials.Veeva

Menu

Inspiratory Muscle Training and Nasal High Flow in Difficult Weaning

E

Evangelismos Hospital

Status

Unknown

Conditions

Weaning Outcome
High-risk for Reintubation Patients

Treatments

Other: Inspiratory muscle Training and Nasal High Flow
Device: Inspiratory muscle training and Venturi mask

Study type

Interventional

Funder types

Other

Identifiers

NCT03908658
6345/14-03-2019

Details and patient eligibility

About

The purpose of the present study is to investigate the effectiveness of inspiratory muscle training and nasal high flow oxygen in patients with difficult weaning and high-risk for re-intubation. The hypothesis of the study is that starting inspiratory muscle training once patients are awake and co-operative along with the application of nasal high flow oxygen immediately after extubation will have a beneficial effect in preventive re-intubation in these high-risk patients.

Full description

20-30% of intubated patients are difficult to be weaned off the mechanical ventilation and have a prolonged ICU stay. It is well established that prolonged ICU stay is associated with reduced muscle strength, functional ability and quality of life.

Inspiratory muscle training (IMT) via a threshold device has been proposed as an effective exercise for minimizing the detrimental effect of mechanical ventilation in critical ill patients with prolonged weaning. Additionally, Nasal High Flow (NHF) oxygen has been proved to support efficiently either high or low-risk patients after extubation and thus preventing re-intubation.

A randomized intervention study was designed to assess the efficacy of combining IMT and NHF as therapeutic strategies for difficult weaning. Once patients with prognostic factors of difficult weaning are awake and co-operative they will be randomized to one of the two following study groups: 1) IMT and NHF group, 2) IMT and Venturi mask group. IMT will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Each allocated oxygen delivery device will be applied immediately after extubation. IMT intervention will continue until patients' discharge from the ICU.

Enrollment

146 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >65 years,
  • BMI> 35kg/m2,
  • weak cough,
  • heart (i.e heart failure ) and lung comorbidities (i.e COPD),
  • hypercapnia during mechanical ventilation
  • > 72hours on mechanical ventilation
  • failed first spontaneous breathing trial

Exclusion criteria

  • Glasgow Coma scale (GCS)<13,
  • pre-existing neuromuscular disease or deformity of Spinal Cord,
  • terminal disease
  • hemodynamic instability with >0.1μg/kg/min noradrenaline
  • patients of immediately need of Non-invasive ventilation after extubation

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

146 participants in 2 patient groups

Inspiratory Muscle Training and Nasal High Flow
Active Comparator group
Description:
Inspiratory Muscle Training will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Nasal High Flow will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU
Treatment:
Other: Inspiratory muscle Training and Nasal High Flow
Inspiratory Muscle Training and Venturi mask
Active Comparator group
Description:
IMT will start as soon as the patient wakes up and is cooperative, ventilated with support settings. Venturi mask will be applied immediately after extubation. IMT intervention will continue until patient's discharge from the ICU
Treatment:
Device: Inspiratory muscle training and Venturi mask

Trial contacts and locations

1

Loading...

Central trial contact

Anna Christakou; Irini Patsaki

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems